Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| BAKER BROS ADVISORS LP | 11-14-2023 | 09-30-2023 | 101 | 17,351,037,330 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | COM | 51 | $25,675,988 | 751,639 | 0.00 | 0.18 | 0 | 0.00 | 09-30-2023 |
| Cabaletta Bio, Inc. | COM | 52 | $24,260,680 | 1,594,000 | 0.00 | 0.00 | 931,937 | 140.76 | 09-30-2023 |
| Monte Rosa Therapeutics, Inc. | COM | 53 | $23,548,095 | 4,916,095 | 0.00 | 4,916,095 | +Inf | 09-30-2023 | |
| DBV Technologies S.A. | SPONSORED ADR | 54 | $19,875,399 | 14,614,264 | 0.00 | 0.17 | 0 | 0.00 | 09-30-2023 |
